A $160 billion deal announced Monday to merge Pfizer and Allergan and create the world’s biggest drug company renewed the outcry in Washington over “inversions,” in which U.S. corporations combine with companies overseas to lower their tax bill.
The combination — the second-largest merger in history — could have ramifications around the globe, pushing up drug prices and spurring more such deals in the fast-consolidating health care sector and other fields.
18:05 DP World, Quebec's Caisse to create C$5 billion investment vehicle12
01:02 A company Trump attacked will receive state tax breaks to keep jobs in the U.S11
18:42 Stores with Cyber Monday 2016 Deals: List of biggest retailers participating this year12
14:47 Gambian president said he would rule for a ‘billion years.’ He just lost reelection13